This study clearly showed the efficacy of TFF1, if treated with gemcitabine, in inhibiting the tumor growth of pancreatic cancer in a xenograft model, suggesting that TFF1 might be useful to develop novel treatment for pancreatic cancer. The gene discussed is TFF1; the disease is familial pancreatic carcinoma.